We are developing a cold sterilization technology that is rapidly biocidal against fungi, viruses, bacteria and bacterial spores, but is neither toxic nor mutagenic to higher organisms. The biocidal activity remains potent for long times, is non-corrosive to 200 and 400 grade stainless steel instruments, does not stain or smell and can be produced for less than 1/50th the cost of presently used cold sterilant products. We will determine the optimal conditions for cold sterilization of medical instruments with respect to specific pathogens using American Association of Analytical Chemists protocols. We will also perform shelf-life studies using accelerated thermal stressed cycling to verify an acceptable shelf- life. It is expected that these studies will demonstrate the effectiveness of this cold sterilization technology for delicate surgical instruments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI032840-01
Application #
3489636
Study Section
Special Emphasis Panel (SSS (B1))
Project Start
1992-05-01
Project End
1992-10-31
Budget Start
1992-05-01
Budget End
1992-10-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Biomedical Development Corporation
Department
Type
DUNS #
City
San Antonio
State
TX
Country
United States
Zip Code